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septal: 97.6%; p¼ns) and procedural complication (AV groove 4.1%,
epicardial 4.8%, septal 2.4%; p¼ns) rates were achieved in the 3
subgroups.
CONCLUSIONS In real world retrograde CTO PCIs, selection of
collateral channel guided by a proposed hierarchic decision algorithm
achieved high technical success rate and low procedural complication
rate. With liberal but rational selection, AV groove, epicardial, or
septal collateral channels may all be used with similar technical suc-
cess and procedural complication rates.
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BACKGROUND Bifurcation treatment using the provisional strategy
with routine ﬁnal kissing balloon dilatation (FKBD) have resulted in
longer and more complex procedures compared to a strategy of no
FKBD. FKBD may reduce delayed strut coverage and ﬂow limiting
neointimal growth on stent struts jailing the side branch ostium.
However, stent distortion after FKBD may negatively affect vessel
healing. We present the 5-year clinical follow-up in the Nordic-Baltic
Bifurcation Study III (NCT00914199) on routine vs. no FKBD.
METHODS 477 patients with a bifurcation lesion were randomized to
FKBD (n¼238) or no-FKBD (n¼239) after main vessel stenting. The 6-
month primary end-point was a composite of major adverse cardiac
events (MACE); cardiac death, non-procedure related index lesion
myocardial infarction, target lesion revascularization or deﬁnite stent
thrombosis.
RESULTS Five-year follow-up was available in 472 (99%) patients.
The 5-year MACE rate was 14.5% in the FKBD group compared to 13.1%
(p¼0.66) in the no-FKBD group. All-cause mortality was observed in
9.8% vs. 3.8% (p¼0.01), cardiac death in 4.2% vs. 0.8% (p¼0.02), non-
procedural myocardial infarction in 4.3% vs. 4.7% (p¼0.83), target
lesion revascularization in 8.5% vs. 10.1% (p¼0.55), and deﬁnite stent
thrombosis in 0.8% vs. 1.3% (p¼0.66) of patients in the FKBD and no-
FKBD groups, respectively. In the subgroup of true bifurcation lesions
(n¼235) 5-year MACE rates were 16.0% in the FKBD group vs. 18.1%
(p¼0.66) in the no-FKBD group.
CONCLUSIONS A strategy of routine FKBD compared to no FKBD, in
main vessel-only stenting did not improve 5-year clinical outcome
after treatment of coronary bifurcation lesions. Cardiac mortality and
all-cause mortality were signiﬁcantly increased in the routine FKBD
group at 5 years.
CATEGORIES CORONARY: Complex and Higher Risk Procedures for
Indicated Patients (CHIP)CONGENITAL HEART DISEASE AND
OTHER STRUCTURAL INTERVENTIONS
Tuesday, October, 13, 2015, 2:00 PM-4:00 PM
Abstract nos: 26 - 34TCT-26
Balloon Pulmonary Angioplasty Driven By Combined Assessment of Intra-
Arterial Anatomy And Physiology In Patients With Non Operable Distal
Chronic Thromboembolic Pulmonary Hypertension
Marek Roik,1 Dominik Wretowski,1 Andrzej Łabyk,1 Katarzyna Irzyk,1
Maciej Kostrubiec,1 Piotr Pruszczyk1
1Department of Internal Medicine and Cardiology, Warsaw Medical
University, Warsaw, Poland
BACKGROUND Balloon pulmonary angioplasty (BPA) is an emerging
therapeutic method in CTEPH. We aimed to prove the safety and ef-
ﬁcacy of reﬁned BPA driven by combined assessment of intra-arterial
anatomy (IVUS/OCT) and physiology (pulmonary pressure ratio, PPR)
in non-operable distal CTEPH.
METHODS 11 pts (mean age 76, 59-84, 7males) were enrolled in the BPA
program according to the following inclusion criteria: 1. Non-operable
CTEPH; 2. RHC with mPAP >30mmHg; 3. At least one segmental
perfusion defect at lung scintigraphy; 4. WHO class > II. Overall, 9 pts
underwent 27 BPA sessions, 50 pulmonary arteries were dilated (mean
6 vessels per patient, range 3-9; 2.03 dilated arteries per session). All the
angioplasties were performed according to an algorithm, which incor-
porated anatomical and functional assessment of targeted lesions.
RESULTS We performed BPA of 32 web lesions, 5 ring-like stenosis
and 13 complete obstructions. BPA resulted in clinical and hemody-
namic improvement. WHO class improved from pre-BPA to post-BPA
(p¼0.011), and 6 MWD increased from 304m to 384m (p ¼0.03), NT-
proBNP dropped from 1248 pg/ml to 730pg/ml (p¼0.007). Mean PAP
and PVR decreased (p¼0.01), while CO and CI increased (p¼0.01). All
dilated arteries were patent at angiographic reassessment. No signif-
icant complications occurred and all treated patients are still alive.
Insigniﬁcant transient reperfusion pulmonary edema (RPE) occurred
in only 2 patients, who responded well to supplemental oxygen.
CONCLUSIONS BPA with assessment of intrapulmonary physiology
using a pressure wire and precise evaluation of anatomy with IVUS
and OCT provides hemodynamic and functional improvement, with
minimal complications in distal non-operable CTEPH. This observa-
tion requires further validation in a large prospective study.
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BACKGROUND Pulmonary vein stenosis (PVS) is a rare, but serious
complication of pulmonary vein isolation resulting in debilitating
symptoms including cough, chest pain, dyspnea, hemoptysis, and
pulmonary infarction. Despite advances in interventional techniques,
re-stenosis after PV dilation and/or stenting is a signiﬁcant and
common complication with no conclusive data regarding recurrence
with balloon angioplasty versus stenting. We sought to ascertain the
incidence of PVS recurrence after an initially successful intervention,
and evaluate procedural characteristics which might have prognostic
implications on predicting future restenosis.
METHODS We abstracted baseline demographic data, date and
method of PVS diagnosis, and presenting symptoms on patients who
underwent an incident PVS intervention between November 2000 and
November 2014. We charted PVS interventional procedural data
